Cargando…

The Immunosuppressant Mycophenolic Acid Alters Nucleotide and Lipid Metabolism in an Intestinal Cell Model

The study objective was to elucidate the molecular mechanisms underlying the negative effects of mycophenolic acid (MPA) on human intestinal cells. Effects of MPA exposure and guanosine supplementation on nucleotide concentrations in LS180 cells were assessed using liquid chromatography-mass spectro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heischmann, Svenja, Dzieciatkowska, Monika, Hansen, Kirk, Leibfritz, Dieter, Christians, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361167/ https://www.ncbi.nlm.nih.gov/pubmed/28327659 http://dx.doi.org/10.1038/srep45088

Ejemplares similares

Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
por: Iqbal, Asma, et al.
Publicado: (2020)

Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism
por: Klawitter, Jelena, et al.
Publicado: (2014)

Effective delivery of mycophenolic acid by oxygen nanobubbles for modulating immunosuppression
por: Khan, Muhammad Saad, et al.
Publicado: (2020)

Inhibition of tRNA Gene Transcription by the Immunosuppressant Mycophenolic Acid
por: Jurkiewicz, Aneta, et al.
Publicado: (2019)

Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents
por: Walczak, Juliusz Maksymilian, et al.
Publicado: (2022)

Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid
por: de Ruiter, Petra E, et al.
Publicado: (2018)

Mycophenolic Acid Derivatives with Immunosuppressive Activity from the Coral-Derived Fungus Penicillium bialowiezense
por: Zhang, Qing, et al.
Publicado: (2018)

Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease
por: Taylor, Erin B., et al.
Publicado: (2017)

CMV retinitis in patients on mycophenolate immunosuppression: a report of two cases
por: Patel, Prem N., et al.
Publicado: (2023)

Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics
por: Feturi, Firuz G., et al.
Publicado: (2018)

Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases
por: Li, Yuce, et al.
Publicado: (2021)

Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension
por: Satou, Ryousuke, et al.
Publicado: (2022)

Immunosuppressant mycophenolic acid biosynthesis employs a new globin-like enzyme for prenyl side chain cleavage
por: Chen, Xiwei, et al.
Publicado: (2019)

Mycophenolic Acid Induces the Intestinal Epithelial Barrier Damage through Mitochondrial ROS
por: Deng, Yiyun, et al.
Publicado: (2022)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Evaluation on physiological biomarkers pre and during gestational period in immunosuppressed Wistar rats with mycophenolate sodium
por: Deluque, Amanda Lima, et al.
Publicado: (2015)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults
por: Groll, Andreas H., et al.
Publicado: (2016)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013)

Rapid intestinal and systemic metabolic reprogramming in an immunosuppressed environment
por: Ma, Bing, et al.
Publicado: (2023)

Exploratory Metabolomics Profiling in the Kainic Acid Rat Model Reveals Depletion of 25-Hydroxyvitamin D3 during Epileptogenesis
por: Heischmann, Svenja, et al.
Publicado: (2016)

A comprehensive characterization of the impact of mycophenolic acid on the metabolism of Jurkat T cells
por: Fernández-Ramos, Ana A., et al.
Publicado: (2017)

Altered Intestinal Microbiomes and Lipid Metabolism in Patients With Prolonged Disorders of Consciousness
por: Yu, Jie, et al.
Publicado: (2022)

Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study
por: Klawitter, J, et al.
Publicado: (2009)

Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study
por: Hanisch, F, et al.
Publicado: (2009)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Successful Triple Combination Immunosuppressive Therapy with Prednisolone, Cyclosporine, and Mycophenolate Mofetil to Treat Recurrent Giant Cell Myocarditis
por: Akita, Tomomi, et al.
Publicado: (2019)

Phosphorylation of the Scc2 cohesin deposition complex subunit regulates chromosome condensation through cohesin integrity
por: Woodman, Julie, et al.
Publicado: (2015)

Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
por: Bleve, Augusto, et al.
Publicado: (2020)

Probiotics treatment ameliorated mycophenolic acid-induced colitis by enhancing intestinal barrier function and improving intestinal microbiota dysbiosis in mice
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Combined Reversed Phase HPLC, Mass Spectrometry, and NMR Spectroscopy for a Fast Separation and Efficient Identification of Phosphatidylcholines
por: Willmann, Jan, et al.
Publicado: (2011)

mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis
por: Xie, Xishao, et al.
Publicado: (2015)

Exposure to Mycophenolate and Fatherhood
por: Midtvedt, Karsten, et al.
Publicado: (2017)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Innovations in Immunosuppression for Intestinal Transplantation
por: Dogra, Harween, et al.
Publicado: (2022)

Fructooligosaccharide raftilose reduces the mycophenolate mofetil-induced complications: Hematological and biochemical alterations
por: Cheraghi, Hadi, et al.
Publicado: (2015)

Mycophenolate mofetil toxicity mimicking acute cellular rejection in a small intestinal transplant
por: Apostolov, Ross, et al.
Publicado: (2017)

De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression
por: Friedersdorff, F., et al.
Publicado: (2010)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_l8du5956bp2gbv4tf232h85s01